Philippine’s One Dex Cel Pharma shows intent to acquire 65pc equity stake in Haydery Construction

Karachi: In a notification sent to the bourse on Friday by Topline Securities announced the intention of Philippines based One Dex Cel Pharma Inc to acquire 65pc majority stake in Haydery Construction Company Ltd.

The notification read Topline Securities would be acting as the Manager to the Offer by Acquirers i.e. One Dex Cel Pharma Inc from Philippines. It said that One Dex Cel Pharma intended to acquire 4,160,000 ordinary shares of the total issue shared capital of Haydary Construction Company Limited.

Haydery Construction is in the business of carrying out all types of construction and contracting business. One Dex Cel Pharma of the Philippines is a drug importer.

At the time of filing this report, Haydery Construction’s shares were trading at Rs16.91, up by Rs0.91 from its close on Thursday. KSE-100 index was trading at 39,770.42 points, down 467.11 points in the first hour of trading.

Must Read